"The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
GEMCITABINE - INJECTION
COMMON BRAND NAME(S): Gemzar
USES: Gemcitabine is used alone or with other treatments/medications to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.
This drug may also be used to treat certain other cancers, such as bladder cancer.
HOW TO USE: Read the Patient Information Leaflet if available from your healthcare professional before you start receiving gemcitabine and each scheduled dose. If you have any questions, ask your healthcare professional.
This medication is given by injection into a vein by a healthcare professional, usually over 30 minutes once a week or as directed by your doctor. The dosage is based on your medical condition and response to therapy.
If this medication touches your skin, wash the skin immediately and completely with soap and water.
Additional Gemzar Information
Gemzar - User Reviews
Gemzar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get the latest treatment options.